SINOMED

🎉🎉🎉 Excited to announce that #HTSupreme has officially been launched in Mexico in collaboration with our partner SinoCare. Thanks to the team of Centro Médico Nacional de Occidente IMSS in #Guadalajara for performing the first case and shared in the session of Bifurcation & Imaging at Citic México. We look forward to the exciting steps onwards! Learn more about SINOMED or #HTSupreme and our other new projects? Feel free follow us or reach out to Cindy Zheng.

Looking forward to meet our customers, partners and industry community in Shanghai. SINOMED: Hall5.2 K41. #CMEF2024 #SINOMED

🌍 National Doctors' Day: A Global Salute to Healthcare Heroes 💖 Today, we pay tribute to healthcare heroes worldwide. Our coronary & neuro intervention products aid your skilled efforts to save lives. Your dedication, precision, & compassion inspire us. On National Doctors' Day, we honor your tireless work & commitment to patient care. Thank you for your unwavering dedication to safeguard patient's health. #NationalDoctorsDay #HealthcareHeroes #SINOMED

Congratulations to our Brazilian partner, Biomedical Produtos Ltda, on the successful launch of the #HTSupreme #DES! We’re thrilled and fully committed to furthering our contribution to the #pcicommunity and enhancing patient safety outcomes in Brazil. #interventionalcardiology #electroGrafting #healing #coronary

🎉 Happy Lunar New Year from SINOMED! 🐉 As we welcome the majestic Year of the Dragon, we extend our warmest wishes to you and your loved ones for a year filled with prosperity, joy, and success. May the Dragon bring you strength, courage, and abundance in all your endeavors. At SINOMED, we are dedicated to pushing boundaries, driving innovation, and building lasting partnerships. As we celebrate this auspicious occasion, we express our heartfelt appreciation to our esteemed clients, collaborators, and team members for their continuous support and dedication. Let's embrace the energy of the Dragon with determination, resilience, and a spirit of unity. Together, let's make 2024 a year of remarkable achievements and memorable milestones. Wishing you a prosperous and fulfilling Lunar New Year! #SINOMED #Lunarnewyear #chinesenewyear #theyearofdragon

🍾🤩 Le stent #HTSupreme de SINOMED a obtenu le statut de dispositif médical remboursé par le Ministère de la Santé et Ministère de l’Économie, des Finances et de la Souveraineté industrielle et numérique L'attribution des codes LPPR a été officiellement publiée au JO du 21/09/23. Nous sommes fiers de ce dispositif et des origines Françaises de sa technologie basée sur l’électro-greffage (eG), aujourd’hui implantée dans plus de 1 millions de patients à travers le monde. C’est en 2014 qu’AlchiMedics S.A.S. – essaimage du Commissariat a l'Energie Atomique et aux Energies Alternatives – et SINOMED ont remporté le Prix des Innovations Franco-Chinoises décernées conjointement par l’INPI France et le SIPO, sous le patronage du COMITÉ FRANCE CHINE: https://lnkd.in/eWmPqfXZ Il s’agit pour SINOMED non seulement d’un jalon majeur, mais aussi d’une occasion de célébrer cette collaboration innovante entre la France et la Chine, débutée dès 2005.  ------------------------------------------------------------------------------------- 🍾🤩 SINOMED's #HTSupreme stent has been granted reimbursed medical device status by the French ministry of Health and Economics! The allocation of LPPR codes has been officially published in the Gazette of the French Republic (JO) on 09/21/23. We are proud of this device and of the French origin of its technology of electro-grafting (eG), now implanted in over 1 million patients worldwide. It was in 2014 when AlchiMedics S.A.S. - a spin-off from Commissariat a l'Energie Atomique et aux Energies Alternatives - and SINOMED won the “French-Chinese Innovation award” jointly by INPI France and SIPO, under the patronage of COMITÉ FRANCE CHINE: https://lnkd.in/eWmPqfXZ For SINOMED, this is not only a major milestone, but also an opportunity to celebrate an innovative collaboration between France and China that began in 2005. #DrugElutingStent, La French Tech

Happy World Heart Day! This day raises global awareness to the importance of prevention and control of Cardiovascular Diseases (CVD). This year the theme for World Heart Day 2023 is 'Use Heart, Know Heart'. Knowledge will empower us and is the first step to maintaining a healthy heart. Understanding the risks and taking precautions will help each of us to take control of our well-being.   At #SINOMED, we care about everybody's heart health and aim to serve patients wholeheartedly through continuous innovations in #cardiovascular interventional medical devices.   Thanks to #worldheartfoundation for this day of awareness and our team/partners who continue to work towards achieving this goal.   #Worldheartday2023 #Heartawareness #CVD

We would like to thank Pieter Smits, one of our steering committee member of the PIONEER IV trial for sharing the fundamentals of the Healing-Targeted Supreme stent at the #ENCORE congress in Seoul!    This contemporary #DES is designed to boost #EarlyFunctionalHealing through: -    An unique drug release kinetics: we minimize the contamination of tissue by the drug and the delay in endothelial cell migration through rapid drug release. -    Re-endothelialization booster: our coating is based on a nanometric #ElectroGrafted primer layer which accelerates healing.    Through evidence supported by pre-clinical, imaging and clinical trials of 5000+ patients worldwide, we at SINOMED continuously strives to deliver a its best-in-class device for patients ensuring the safest outcomes. Latest ongoing post-market clinical program #PIONEER IV an investigator initiated University of Galway sponsored trial, led by Prof.Patrick Serruys and centrally managed by CORRIB Research Centre for Advanced Imaging and Core Laboratory, is an exciting all-comers study which will have a special focus the healing profile of the device, evaluating the clinical outcomes of 1-Month DAPT regimen post PCI among 2500+ patients.    The expected MFDS approval of #HTSupreme #DES is anticipated to be Q2 2024 in South-Korea. #ElectroGrafting is a technology developed by AlchiMedics S.A.S. under license from CEA”   Contact us or scan below to learn more about #HTSupreme and this presentation.